TrialNature communications2022

The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma.

Daniel J Renouf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.